Active Trader

ThinkstockPhotos-475472230

Top Analyst Upgrades and Downgrades: Amazon, Ford, Gilead, Level 3, Sarepta, Western Digital, Whiting Petroleum and More

Stocks had a rough Thursday and futures were indicated lower on Friday. Despite the drop, we have yet to see any serious selling pressure in a while and investors still ...
Read Full Story »
clinical trials

Gilead Results Trip Over Both the Top and Bottom Lines

Gilead Sciences Inc. (NASDAQ: GILD) reported first-quarter financial results after the markets closed on Thursday. The company had $3.03 in earnings per share (EPS) on $7.79 billion in revenue compared ...
Read Full Story »
hammer and nail

FINRA’s First Report Cards on Spoofing and Layering

FINRA, the Financial Industry Regulatory Authority, has issued its first cross-market report cards covering the acts of spoofing and layering orders. These are common complaints about high frequency trading and ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Facebook, First Solar, Hess, Texas Instruments, US Steel, Vertex, Infinera and More

Stocks were indicated to open handily lower on Thursday, after a disappointing no-change stance from the Bank of Japan caused stocks to slide globally. Despite the prices on Thursday, the ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Apple, Chipotle, eBay, JetBlue, Kraft Heinz, Twitter, Gap, NOV and More

Stocks were indicated lower on Wednesday, partly dragged down by a disappointing Apple earnings report. It still seems that investors have returned to a mentality of buying the pullbacks rather ...
Read Full Story »
Pocket iPhone

Are Apple Earnings Suggesting a Fundamental Change?

Apple Inc. (NASDAQ: AAPL) reported fiscal second-quarter financial results after the markets closed on Tuesday. The company had $1.90 in earnings per share (EPS) on $50.6 billion in revenue versus ...
Read Full Story »
FDA_logo

Why This Isn’t the End of Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX) saw its shares get halved just Tuesday morning alone, following a business update regarding its Lambert-Eaton myasthenic syndrome (LEMS) treatment. The company provided an update ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: Broadcom, Caterpillar, Sirius XM, Newmont, Palo Alto, Perrigo, Sarepta, Xerox and More

Stocks were indicated marginally higher on Tuesday, but the markets still seem to be looking for a new directional bias after weeks of rallies took the market back to 2016 ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Baidu, Caterpillar, GE, Honeywell, Kimberly-Clark, Schlumberger, Southern Energy and More

Stocks were trading lower on Monday ahead of this week's slate of central bank meetings. Still, investors have clearly reverted back to the steady trend of buying pullbacks that prevailed ...
Read Full Story »
graph

Parnell Pharma Soars on Business Update

Parnell Pharmaceuticals Holding Ltd. (NASDAQ: PARN) saw its shares take a sharp uptick into the weekend following a solid business update. The company announced business results for the first quarter of ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Alphabet, Apple, Microsoft, Five Below, Ericsson, United Rentals and More

Stocks were looking for direction Friday morning, quite similar to Thursday morning. Still, with the market effectively being near 2016 highs, there has been a willingness for risk again. Investors have ...
Read Full Story »
ThinkstockPhotos-475472230

Top Analyst Upgrades and Downgrades: Abbott Labs, Amex, Apple, Citrix, ConocoPhillips, Kinder Morgan, Qualcomm, ServiceNow, Tesla and More

Stocks were looking for direction on Thursday, but the market is effectively at the 2016 highs. Investors have clearly reverted back to the trend of buying pullbacks that prevailed from ...
Read Full Story »
graph

Spectrum Pharma Jumps on FDA Orphan Designation

Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) saw its shares rise early on Wednesday after earning an Orphan designation. The company announced that the U.S. Food and Drug Administration (FDA) Office of Orphan ...
Read Full Story »
FDA_logo

Cara Therapeutics Rises on FDA Judgment

Cara Therapeutics Inc. (NASDAQ: CARA) saw its shares jump early on Wednesday after the U.S. Food and Drug Administration (FDA) made a favorable judgment for them. The company announced that ...
Read Full Story »
buy sell stocks

Top Analyst Upgrades and Downgrades: ArcelorMittal, Boeing, Intel, Schlumberger, Yahoo, Vivint Solar, Johnson & Johnson and More

Stocks were indicated higher yet again on Wednesday, with the Dow over 18,000 and the S&P 500 back at 2,100. The memories of all the selling pressure during the first ...
Read Full Story »